Unilateral Optic Pathway Gliomas in the Absence of Other Features of Neurofibromatosis Type 1 are not Suggestive of a Diagnosis of this Syndrome

被引:0
|
作者
Wang, V. [1 ]
Reichman, L. [2 ]
Felton, K. [3 ]
Foulkes, W. [4 ,5 ]
Tabori, U. [6 ]
Malkin, D. [6 ]
Goudie, C. [7 ]
机构
[1] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada
[2] McGill Univ, Hlth Ctr, Child Hlth & Human Dev, Res Inst, Montreal, PQ, Canada
[3] Jim Pattison Childrens Hosp, Pediat Hematol Oncol, Saskatoon, SK, Canada
[4] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada
[5] McGill Univ, Jewish Gen Hosp, Dept Human Genet, Lady Davis Inst, Montreal, PQ, Canada
[6] Hosp Sick Children, Pediat Hematol Oncol, Toronto, ON, Canada
[7] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Pediat,Div Hematol Oncol, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
0448
引用
收藏
页码:S203 / S204
页数:2
相关论文
共 50 条
  • [31] OPTIC GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE-1
    LISTERNICK, R
    CHARROW, J
    GREENWALD, MJ
    ESTERLY, NB
    JOURNAL OF PEDIATRICS, 1989, 114 (05): : 778 - 792
  • [32] Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations
    Listernick, Robert
    Ferner, Rosalie E.
    Liu, Grant T.
    Gutmann, David H.
    ANNALS OF NEUROLOGY, 2007, 61 (03) : 189 - 198
  • [33] White matter properties of the optics pathway in children with neurofibromatosis type 1 with and without optic pathway gliomas
    Bruckert, L.
    Lerma-Usabiaga, G.
    Beres, S.
    McKenna, E.
    Yeom, K.
    Travis, K.
    Campen, C.
    ANNALS OF NEUROLOGY, 2022, 92 : S29 - S30
  • [34] Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1
    de Blank, Peter Matthew Kennedy
    Berman, Jeffrey Ira
    Liu, Grant T.
    Roberts, Timothy Paul Leslie
    Fisher, Michael Jay
    NEURO-ONCOLOGY, 2013, 15 (08) : 1088 - 1095
  • [35] Optic pathway gliomas in Neurofibromatosis Type 1: Natural history, treatment and the psychosocial impact.
    Sharif, S
    Ferner, R
    Macleod, R
    Hopwood, P
    Birch, J
    Majounie, E
    Upadhyaya, M
    Evans, DGR
    JOURNAL OF MEDICAL GENETICS, 2004, 41 : S24 - S24
  • [36] Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision
    de Blank, Peter M. K.
    Fisher, Michael J.
    Liu, Grant T.
    Gutmann, David H.
    Listernick, Robert
    Ferner, Rosalie E.
    Avery, Robert A.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2017, 37 : S23 - S32
  • [37] Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
    Tang, Yunshuo
    Gutmann, David H.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 667 - 681
  • [38] The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1
    Prada, Carlos E.
    Hufnagel, Robert B.
    Hummel, Trent R.
    Lovell, Anne M.
    Hopkin, Robert J.
    Saal, Howard M.
    Schorry, Elizabeth K.
    JOURNAL OF PEDIATRICS, 2015, 167 (04): : 851 - +
  • [39] Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas
    Chang, Lan
    El-Dairi, Mays A.
    Frempong, Tamiesha A.
    Burner, Erica L.
    Bhatti, M. Tariq
    Young, Terri L.
    Leigh, Fawn
    JOURNAL OF AAPOS, 2010, 14 (06): : 511 - 517
  • [40] Optic pathway gliomas in patients with neurofibromatosis type 1: Follow-up of 44 patients
    Segal, Laura
    Darvish-Zargar, Mahshad
    Dilenge, Marie-Emmanuelle
    Ortenberg, June
    Polomeno, Robert C.
    JOURNAL OF AAPOS, 2010, 14 (02): : 155 - 158